These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35752301)

  • 1. Expectant vs medical management for retained products of conception after medical termination of pregnancy: a randomized controlled study.
    Tzur Y; Berkovitz-Shperling R; Goitein Inbar T; Bar-On S; Gil Y; Levin I; Cohen A
    Am J Obstet Gynecol; 2022 Oct; 227(4):599.e1-599.e9. PubMed ID: 35752301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of using vaginal misoprostol for treatment of retained products of conception after first trimester miscarriage: a retrospective cohort study.
    Stewart KT; Lee JS; Pan K; Albert AY; Fisher S
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):474-479. PubMed ID: 32869658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial.
    Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW;
    Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
    Chung T; Leung P; Cheung LP; Haines C; Chang AM
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility and obstetric outcomes after curettage versus expectant management in randomised and non-randomised women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Lemmers M; Verschoor MAC; Overwater K; Bossuyt PM; Hendriks D; Hemelaar M; Schutte JM; Adriaanse AH; Ankum WM; Huirne JAF; Mol BWJ
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():78-82. PubMed ID: 28199872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misoprostol versus expectant management in women with incomplete first-trimester miscarriage after failed primary misoprostol treatment: A randomized clinical trial.
    Ali MK; Emam SM; Abdel-Aleem MA; Sobh AMA
    Int J Gynaecol Obstet; 2021 Sep; 154(3):558-564. PubMed ID: 33615468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of incomplete abortion related to treatment modality.
    Sharvit M; Yagur Y; Shams R; Daykan Y; Klein Z; Schonman R
    Arch Gynecol Obstet; 2023 Nov; 308(5):1543-1548. PubMed ID: 37653249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.
    Lemmers M; Verschoor MAC; Bossuyt PM; Huirne JAF; Spinder T; Nieboer TE; Bongers MY; Janssen IAH; Van Hooff MHA; Mol BWJ; Ankum WM; Bosmans JE;
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):294-300. PubMed ID: 29266169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive outcome after early miscarriage: comparing vaginal misoprostol treatment with expectant management in a planned secondary analysis of a randomized controlled trial.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):100-106. PubMed ID: 34523740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between history of retained placenta and success rate of misoprostol treatment for early pregnancy failure.
    Cohen A; Gutman-Ido E; Karavani G; Albeck A; Rosenbloom JI; Shushan A; Chill HH
    BMC Womens Health; 2023 Oct; 23(1):523. PubMed ID: 37794425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical vs. surgical evacuation of first-trimester spontaneous abortion.
    Moodliar S; Bagratee JS; Moodley J
    Int J Gynaecol Obstet; 2005 Oct; 91(1):21-6. PubMed ID: 16051242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage.
    Bagratee JS; Khullar V; Regan L; Moodley J; Kagoro H
    Hum Reprod; 2004 Feb; 19(2):266-71. PubMed ID: 14747165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letrozole pretreatment prior to medical termination of pregnancy: a systematic review.
    Nash CM; Philp L; Shah P; Murphy KE
    Contraception; 2018 Jun; 97(6):504-509. PubMed ID: 29154779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Office Hysteroscopy in Diagnosing Retained Products of Conception Following Early Pregnancy Loss After In Vitro Fertilization.
    George JS; Naert MN; Lanes A; Yin S; Bharadwa S; Ginsburg ES; Srouji SS
    Obstet Gynecol; 2023 Nov; 142(5):1019-1027. PubMed ID: 37769303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis.
    Sotiriadis A; Makrydimas G; Papatheodorou S; Ioannidis JP
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1104-13. PubMed ID: 15863551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.
    Verschoor MA; Lemmers M; Bossuyt PM; Graziosi GC; Hajenius PJ; Hendriks DJ; van Hooff MA; van Meurs HS; Opmeer BC; van Tulder MW; Bouwma L; Catshoek R; Geomini P; Klinkert ER; Langenveld J; Nieboer TE; van der Ploeg JM; Radder CM; Spinder T; van der Voet LF; Mol BW; Huirne JA; Ankum WM
    BMC Pregnancy Childbirth; 2013 May; 13():102. PubMed ID: 23638956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel method for office aspiration curettage in cases of retained products of conception: A randomized controlled trial.
    Pomeranz M; Goren Gepstein N; Ovadia M; Klein Z; Daykan Y; Schonman R; Arbib N
    Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2076-2081. PubMed ID: 34467531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.